The lost decade of nesiritide.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Perspectives on C-Type Natriuretic Peptide in Cardiometabolic Disease.Journal of the American Heart Association · 2025
   Review
2. Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials.European journal of heart failure · 2019
   Review
3. Discovery ofThe Journal of biological chemistry · 2019
   Article
4. Sweet rescue or surrender of the failing heart?The Journal of biological chemistry · 2019
   Article
5. Acute heart failure management in the USA and Japan: overview of practice patterns and review of evidence.ESC heart failure · 2018
   Review
6. Use of modified diets to prevent aspiration in oropharyngeal dysphagia: is current practice justified?BMC geriatrics · 2018
   Review

Corrections and comments

• Commented on by
  Nesiritide in acute decompensated heart failure.2011
• Comment on
  Effect of nesiritide in patients with acute decompensated heart failure.2011

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as